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Abstract The amplification of low-density lipoprotein (LDL) 
peroxidation in vitro by copper and myoglobin are well-studied 
biochemical approaches for investigating the oxidative modifica-
tion of LDL and its role in the pathogenesis of atherosclerosis. 
Since the acidity of the environment is increased in inflammatory 
sites, the aim of this study was to investigate the effects of acidic 
pH on the oxidisability of LDL mediated by the haem protein 
myoglobin in comparison with that of copper-mediated LDL 
oxidation. The results show that acidic pH enhances myoglobin-
mediated LDL oxidation as measured by conjugated dienes, lipid 
hydroperoxides and electrophoretic mobility, whilst a retardation 
is observed with copper as pro-oxidant; the mechanism probably 
relates to the effects of pH on the decomposition and formation 
of lipid hydroperoxides and the relative influences of copper ions 
and of myoglobin under these conditions. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Cells of the type present in the arterial wall and found in 
atherosclerotic lesions, activated macrophages [1-3], endothe-
lial cells [3,4], smooth muscle cells [5] and lymphocytes [6], 
have been reported to oxidise L D L in vitro. All these cells 
secrete superoxide radicals, hydrogen peroxide and hydrolytic 
enzymes [reviewed in [7]] but, superoxide and the hydrogen 
peroxide generated there from are not very reactive per se 
towards polyunsaturated fatty acids. Their reactivity may, in 
principle, be amplified in the presence of: (i) available delo-
calised haem proteins generating ferryl haem states [8-11], (ii) 
transition metal ions generating hydroxyl radical [12-16], or 
(iii) nitric oxide, forming peroxynitrite [17]. Superoxide radical 
is also more reactive with polyunsaturated fatty acids at lower 
p H values through its protonat ion [18,19]. 
Injury to cells and tissues may enhance the toxicity of the 
active oxygen species by releasing intracellular transition met-
al ions into the surrounding tissue from storage sites, decom-
partmentalised haem proteins or metalloproteins, for example, 
by interaction with accessible proteases or oxidants. Such de-
localised iron and haem proteins have the capacity to decom-
pose hydroperoxides to peroxyl and alkoxyl radicals, exacer-
bating the initial lesion. Thus, oxidation of L D L mediated by 
agents such as transition metal ions or haem proteins is de-
pendent on the presence of preformed lipid hydroperoxides. 
In the presence of preformed lipid hydroperoxides, propaga-
tion of peroxidation can be effected in the vicinity of haem-
containing and iron-containing species, generating alkoxyl 
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and peroxyl radicals, which can amplify the damage by ini-
tiating further rounds of lipid peroxidation [20,21]. 
Since the acidity of the environment is increased in inflam-
matory and ischaemic sites [reviewed in [22]], the aim of this 
study was to investigate the effect of acidic p H on the oxidis-
ability of L D L mediated by the haem protein metmyoglobin 
and to compare the mechanism with that of copper-mediated 
L D L oxidation. The results show that acidic pH enhances 
myoglobin-mediated L D L oxidation, whilst a retardation of 
the early and intermediate stages of L D L oxidation is ob-
served with copper as pro-oxidant. 
2. Materials and methods 
2.1. LDL preparation 
LDL was isolated by a modified version of the method of Chung et 
al. [23]. Venous blood obtained from humans was taken into acid 
citrate-dextrose solution with added EDTA 100 uM at 4°C. The plas-
ma was separated by centrifugation. The LDL was isolated from the 
plasma by a single-step discontinuous density-gradient ultracentrifu-
gation. The plasma density was adjusted to 1.3 g/ml by addition of 
NaBr according to Radding's equation. Ultracentrifuge tubes contain-
ing 20 ml of 0.9% NaCl solution (density = 1.006 g/ml) were underlain 
with aliquots of plasma (density = 1.3g/ml) and centrifuged at 
149 000 Xg for 1 h 45 min at 16°C in a Beckman L70 ultracentrifuge 
with a Type 70Ti rotor. The LDL fraction was removed and 20 ml 
aliquots placed in ultracentrifuge tubes containing 6 ml of NaBr sol-
ution with 100 uM EDTA (density = 1.154 g/ml). The tubes were 
made to volume with NaBr solution (density = 1.063 g/ml) and further 
centrifuged for 14 h at 149000Xg at 16°C in Beckman L70 ultracen-
trifuge. The LDL fraction was recovered and dialysed for 6 h against 
10 mM PBS with 10 iiM EDTA (pH 7.4) at 4°C. The LDL solution 
was sterilised by passing through a 0.2 urn filter (Millipore). 
2.2. Protein determination 
The protein concentration of the LDL was determined by Mark-
well's modified Lowry procedure [24] using crystalline bovine albumin 
as standard. 
2.3. Preparation of metmyoglobin 
Metmyoglobin was purified prior to use [25] as follows: 10 ml of a 
freshly prepared solution of potassium ferricyanide (740 uM) in PBS 
was added to 10 ml of a 400 u,M solution of metmyoglobin (from 
horse heart, Sigma), the solution mixed, left to stand at room temper-
ature for 20 min then applied to a Sephadex G15 column and eluted 
with PBS. The first fraction was collected, mixed well and its absorb-
ance read at 490, 560, 580 and at 700 nm to correct for background 
absorbance. The concentration of metmyoglobin in the column eluate 
was calculated from the extinction coefficients at each wavelength 
using the formula [MetMb]= 146 A490-108 A560 + 2.1 A580 [26]. Ali-
quots of metmyoglobin in PBS were stored at 4°C. 
2.4. Oxidation conditions 
LDL (125 ug protein/ml) was incubated with either 5 itM metmyo-
globin [27] or 1.25 uM copper sulphate [28] in 150 mM NaCl 10 mM 
phosphate buffer solution (PBS), at 37°C, at pH 5, 6 and 7.4. Buffers 
were prepared under the different pH conditions by varying the rela-
tive proportions of the sodium dihydrogen phosphate and disodium 
hydrogen phosphate and the pH was adjusted at the incubation tem-
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perature (37°C). After the requisite incubation period, the LDL oxi-
dation was stopped by adding butylated hydroxytoluene (BHT) (10 
u,M final concentration) prior to the determinations. Assays were 
performed on the same day. The stock solution of BHT was prepared 
in methanol. 
2.5. Total cholesterol determination 
Total cholesterol determination was carried out using an enzymic 
assay (Boehringer) [29]. The colorimetric kit consists of cholesteryl 
esterase, which hydrolyses cholesteryl esters and allows cholesterol 
oxidase to oxidise free cholesterol, generating a chromophore which 
absorbs at 500 nm. 
2.6. Conjugated diene formation 
The progress of LDL oxidation was recorded spectrophotometri-
cally by continuous monitoring of conjugated diene formation [28]. 
Spectra were then recorded from 200-300 nm at 10 min intervals for 
5 h, at 37°C, using an IBM PC2-linked Beckman DU65 spectropho-
tometer fitted with Quant 1 software. The spectra given represent 
increased conjugated diene formation, at the particular time point, 
above that of the control LDL sample. Absorbance values at 234 
nm were measured as a function of time as a marker of the rate of 
conjugated diene formation. 
2.7. Measurement of lipid hydroperoxides 
In order to quantify lipid hydroperoxide formation, the xylenol 
orange (FOX) assay was performed [30]. Nine hundred microlitres 
of FOX reagent (100 uM xylenol orange, 250 uM ammonium ferrous 
sulphate, 90% methanol, 4 mM butylated hydroxytoluene and 25 mM 
H2SO4) were added to 100 ul of sample comprised of 90 ul of LDL 
(125 u.g protein/ml) and 10 ul methanol, and the sample incubated at 
room temperature for 30 min. After centrifugation at 13000 rpm for 
5 min, the absorbance was read at 560 nm against a blank of meth-
anol and FOX reagent. Ninety microlitres of LDL (125 ug protein/ml) 
were incubated with 10 ul of triphenylphosphine (TPP, a reductant of 
hydroperoxides), at room temperature for 30 min. Nine hundred mi-
crolitres of FOX reagent were added and the sample incubated at 
room temperature for a further 30 min. The sample was then centri-
fuged for 5 min and the absorbance was read at 560 nm. The content 
of hydroperoxides was determined by subtracting the absorbance of 
the solution reacted with TPP from that of the incubate in the absence 
of TPP and expressed as uM. Hydrogen peroxide was used to con-
struct a standard curve using a range of 0-20 U.M. 
2.8. Assay of lipid peroxidation products 
The modified thiobarbituric acid assay of [31] was used as a method 
for measuring lipid peroxidation. Briefly, 500 u.1 of 10% (w/v) tri-
chloroacetic acid and 500 ul of thiobarbituric acid (TBA) (0.75 g 
dissolved in 100 ml of 0.1% HC1) were added to each 500 ul aliquot 
of sample and heated at 95°C for 20 min. The absorbance was meas-
ured at 532 nm and that at 580 nm was subtracted to eliminate any 
potential interfering contribution from the haem protein [32]. Hydro-
lysed 1,1,3,3-tetramethoxypropane (TMP) was used as standard. 90 ul 
of TMP were incubated with 3 ml of HC1 (0.1 M) for 20 min at room 
temperature. Afterwards a standard curve in the range of 0-10 U.M 
was constructed. The results were expressed as nmol of malondialde-
hyde (MDA) equivalents per mg of LDL protein. 
2.9. Relative electrophoretic mobility (REM) 
The Beckman Paragon® Lipoprotein System was used to monitor 
the LDL-REM. Five microlitres aliquots were run in barbital buffer 
(pH 8.6) at 100 V for 45 min and the lipoprotein fraction was stained 
using Sudan black B stain. The distance moved towards the anode by 
each sample in relation to that of the control was taken as REM. 
2.10. Statistical method 
Statistical significance was determined by using the unpaired Stu-
dent's t test and accepted at the P < 0.05 level. Because of the varia-
bility in the LDL derived from different individuals, due to such 
factors as diet, life-style, smoking, stress, etc., the experiments were 
performed in triplicate on one preparation and the data were ex-
pressed as mean ± SD. 
3. Results 
When the extent of LDL oxidation by myoglobin (5 iiM) 
was assessed by conjugated diene formation, a progressive 
increase in the oxidation and an enhancement in the rate of 
the propagation phase was observed on reduction of the pH 
from 7.4 to 5 (Fig. 1). In contrast, applying copper (1.25 uM) 
as pro-oxidant, there was a progressive augmentation in the 
lag phase and decrease in the rate of the propagation phase as 
pH fell. 
Fig. 2 shows the comparison between the time courses of 
hydroperoxide formation at pH 7.4 and at pH 5 for myoglo-
bin- and copper-induced LDL oxidation. The oxidation rate 
was enhanced progressively in the case of myoglobin as pro-
oxidant, attaining 28 and 65 u,M levels at pH 7.4 and pH 5.0 
respectively. The rate in the copper oxidation system, how-
ever, was more rapid at pH 7.4 and by 5 h 70% of the per-
oxides had decomposed. Thus, although the level appeared to 
be enhanced by copper-induced oxidation, this was due to a 
delayed peak in the levels of lipid hydroperoxide at acidic pH 
and to less breakdown of the lipid hydroperoxide by 5 h. 
Comparison of the levels of decomposition products of lipid 
hydroperoxides produced on interaction of Cu2+ with LDL to 
those with myoglobin are shown in Table 1. Although at pH 
7.4 myoglobin generated less decomposition products of per-
oxides than Cu2+, with the increase in hydrogen ion concen-
tration to pH 5 the levels produced as a consequence of the 
myoglobin-LDL interaction were increased, implying an en-
hancement in the rate of formation and decomposition of 
peroxides under these conditions. 
Incubation of LDL with 1.25 uM copper at pH 7.4 for 5 h 
caused an extensive modification of apolipoprotein-BlOO 
compared to the response to myoglobin. As the pH decreased, 
the oxidative modification of the apolipoprotein-BlOO was 
less extensive in the case of copper, whereas the myoglobin-
LDL interaction was apparently more effective in modifying 
LDL apolipoprotein-BlOO under acidic conditions (Table 1). 
The oxidation of LDL led to the loss of total cholesterol 
with a more extensive oxidation at pH 7.4 by Cu2+ than by 
myoglobin. However, the lower pH seemed to protect LDL 
Table 1 
Effect of acidic pH on TBARS and apolipoprotein-B-100 oxidative modification 
LDL 
Mb-LDL 
Cu-LDL 
TBARS 
(nmol MDA/mg 
(PH5) 
2.38 ±0.40 
50.97 ±2.58 
48.40 ±2.58NS 
LDL protein) 
(PH6) 
2.38 ±0.80 
36.68 ± 0.99 
47.41 ±2.19" 
(PH 7.4) 
2.38 ±0.60 
14.48 ±1.59 
47.61 ±2.99* 
REM 
(PH5) 
1 
2.91 ±0.17 
2.13 ±0.12" 
(pH6) 
1 
3.47 ±0.66 
2.67±0.19NS 
(pH 7.4) 
1 
2.03 ±0.41 
3.45 ±0.19" 
LDL (125 u.g protein/ml) was incubated in the presence of either 5 uM metmyoglobin or 1.25 (J.M copper sulphate at pH 5, 6 and 7.4 for 5 h at 
37°C. 
•P< 0.0001; **P< 0.001, Cu-LDL vs. Mb-LDL; NS, nonsignificant; data are mean±SD (n = 3). 
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Fig. 1. The effect of pH on the LDL-conjugated diene formation. 
LDL (125 iig protein/ml) was incubated in the presence of either 5 
uM metmyoglobin (A) or 1.25 uM copper (B) for 5 h at 37°C at 
pH 5 ( A ) , pH 6 (■) and pH 7.4 (•). The data represent the 
mean ± SD (n = 3). 
total cholesterol when copper was used as a pro-oxidant, 
while the pro-oxidant activity of myoglobin on LDL choles-
terol oxidation was exacerbated (Table 2). 
4. Discussion 
A number of redox active agents have been demonstrated 
to amplify LDL oxidation by catalysing the decomposition of 
pre-formed endogenous hydroperoxides, for example, copper 
ions [28], metmyoglobin [8-11] and haemoglobin [32] at pH 
7.4. Recent studies have indicated that at acidic pH copper-
mediated LDL oxidation is initially slower than at physiolog-
ical pH [33]. It has been suggested that this may relate to the 
ability of copper to bind to the apolipoprotein-B-100 of LDL 
[34,35]. Nevertheless, although the initial oxidation by copper 
ions is slower at acidic pH, Morgan and Leake [33] noted a 
more rapid uptake by target macrophages at later time points 
of LDL modified under these conditions. In contrast, the rate 
of oxidation of LDL by iron ions alone, being slow under 
physiological conditions, is greater at acidic pH [33,36]. 
Caeruloplasmin (the plasma copper-containing protein) is 
also capable of catalysing LDL oxidation mediated by macro-
phages more rapidly after preincubation of the caeruloplasmin 
39 
at acidic pH [37]. In addition, transferrin (the major iron-
binding protein in plasma), co-incubated with LDL and cys-
teine at pH 5.5, but not pH 7.4, is capable of inducing the 
LDL oxidation, as detected by the formation of breakdown 
products of LDL peroxidation and altered surface charge on 
the apolipoprotein-BlOO [38]. 
The results of this study show that copper ions at 1.25 u,M 
are able to oxidise LDL (125 itg/ml) at pH 7.4 at a much high 
rate than the haem protein myoglobin (5 uM) under the same 
conditions, whereas acidic pH (5.0) enhances the myoglobin-
mediated oxidation but retards that induced by copper. Stud-
ies of others have indicated that, at physiological pH, copper 
is more effective than iron in promoting LDL oxidation 
[15,39,40]. However, under acidic conditions iron and copper 
show opposing responses, iron becoming more effective in 
catalysing the oxidative modification of LDL, whereas copper 
becomes less effective (at least for the early stages of oxida-
tion) [33,36]. 
The mechanism of action of myoglobin on LDL oxidation 
has been shown to be hydroperoxide-dependent [11], catalys-
ing both the formation and decomposition of hydroperoxides. 
Interestingly, O'Brien [20] showed that haem proteins are 
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Fig. 2. The time course of LDL hydroperoxide formation at pH 5 
(•) and 7.4 (■). LDL (125 u.g protein/ml) was incubated in the pres-
ence of either 5 |xM metmyoglobin (A) or 1.25 uM copper sulfates 
(B) at 37°C. The data represent the mean ± SD (n = 3). 
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Table 2 
Effect of acidic pH on cholesterol oxidation 
Loss of LDL total cholesterol (%) 
(pH 5) (pH 7.4) 
Mb-LDL 15.30 ±3.18 8.45 ±1.61 
Cu-LDL 8.06 ±2.84" 12.24 ±0.67* 
LDL (500 ug protein/ml) was incubated in the presence of either 20 
|j,M metmyoglobin or 5 u.M copper sulfate at pH 5 and 7.4 for 5 h at 
37°C. 
*P<0.01; **P<0.05, Cu-LDL vs. Mb-LDL; data are mean±SD 
(« = 3) (native LDL total cholesterol = 1.79 ±0.16 mg/mg LDL pro-
tein; « = 6). 
more effective than inorganic metal ions, such as iron and 
copper at decomposing linoleic acid hydroperoxides under 
acidic conditions and proposed that the increased activity of 
the haem proteins at acidic pH may have been due to the 
increased exposure of the haem moiety. Oxidation induced 
by copper is influenced not only by the levels of pre-existing 
hydroperoxides but also on the potential interactions between 
copper and specific amino acid residues on the apolipopro-
tein-BlOO, which might be expected to show some pH de-
pendency (especially histidine, for example) although this 
has not been well-defined. However, the oxidation by copper 
is clearly retarded at pH 5.0 compared with pH 7.4, as shown 
by the time-dependency of conjugated diene and hydroperox-
ide formation. The observation of different levels of lipid hy-
droperoxides at 5 h incubation but not of TBARS may be due 
to differences in the time courses for oxidation in which 
TBARS reach a maximum and then remain stable or only 
slowly decrease, whereas the lipid hydroperoxides reach a 
peak and gradually decline towards zero [33]. With metmyo-
globin, however, the formation of conjugated dienes, lipid 
hydroperoxides. and TBARS are all increased at acidic pH. 
Less is known about the oxidation of LDL cholesterol 
under acidic conditions. There is a tendency for the LDL total 
cholesterol to become more oxidised at acidic pH in the pres-
ence of myoglobin, compared to the situation with copper, 
where the loss of total cholesterol is less extensive at low 
pH consistent with the other markers of oxidation. However, 
this may be an underestimate of the extent of cholesterol 
oxidation since it has been suggested that the cholesterol ox-
idase assay also measures oxysterols generated during LDL 
oxidation [41]. Interestingly, Hazen et al. [42] reported that, at 
acidic pH, the LDL cholesterol seems to be a preferential 
target for myeloperoxidase, the phagocyte-derived haem pro-
tein recently identified in human atheroma. 
The enhanced pro-oxidant ability of myoglobin at acidic 
pH might derive from the intrinsic property of haem proteins 
to catalyse peroxide formation and decomposition, since, for 
example, haemoglobin and cytochrome c [43] exhibit an en-
hanced pro-oxidant activity towards arachidonic acid under 
acidic conditions, and myoglobin towards microsomal mem-
branes [44]. Caeruloplasmin under similar conditions does not 
display differential effects over the same range of pH values 
(Salah and Rice-Evans, unpublished observations). However, 
others have shown that pre-incubation of caeruloplasmin at 
acidic pH values prior to incubation with LDL and macro-
phages leads to enhanced uptake of the modified LDL by 
target macrophages [37], suggesting that the pretreatment 
modifies the caeruloplasmin in some way. 
In vivo, acidosis within atherosclerotic lesions might have 
consequences for specific potential mechanisms of oxidation 
such as those mediated by nitric oxide [44] or the protonation 
of the superoxide anion [19,46] or the enhanced pro-oxidant 
action of haem proteins or iron in promoting peroxide decom-
position. Other mechanisms might be retarded, for example, 
the early stages of copper-dependent LDL oxidation. 
The findings here demonstrate the amplification of LDL 
oxidation by haem proteins in more acidic environments 
and the retardation of copper-mediated formation of LDL 
hydroperoxides. The implications for the catalysis of further 
oxidation of LDL containing minimal levels of pre-formed 
hydroperoxides (initially formed by lipoxygenase action, diet-
ary intake of lipid peroxides or peroxynitrite-mediated oxida-
tion) suggest that delocalised haem proteins, if present, may 
oxidise LDL more rapidly in regions with a slightly acidic pH, 
such as chronic inflammatory sites, or delocalised iron re-
leased from haem proteins in the presence of excess peroxide 
[10]. 
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